1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Clinical features of posterior fossa tumor patients
Patient Characteristics No. (%) Age at initial diagnosis (yr) Median 4.1 Range 1–20 Sex Male 9 (64) Female 5 (36) Diagnosis Medulloblastoma 7 (50) Pilocytic astrocytoma 4 (29) Ependymoma 2 (14) Choroid plexus papilloma 1 (7) Treatment modalities Surgery only 5 (36) Surgery/chemotherapy 2 (14) Surgery/chemotherapy/radiation therapy 7 (50) Postoperative neurologic status Ataxia 8 (57) Hemiplegia 5 (36) No sequelae 5 (36) Posterior fossa syndrome 3 (21)